Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 March 2008, Vol. 111, No. 6, pp. 3081-3089.
Prepublished online as a Blood First Edition Paper on January 8, 2008; DOI 10.1182/blood-2006-10-053371.


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
blood-2006-10-053371v1
111/6/3081    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Ullerås, E.
Right arrow Articles by Nilsson, G.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ullerås, E.
Right arrow Articles by Nilsson, G.
Related Collections
Right arrow Immunobiology
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

IMMUNOBIOLOGY

NFAT but not NF-{kappa}B is critical for transcriptional induction of the prosurvival gene A1 after IgE receptor activation in mast cells

Erik Ullerås1,2, Mats Karlberg1, Christine Möller Westerberg1, Jessica Alfredsson1, Steve Gerondakis3, Andreas Strasser3, and Gunnar Nilsson1

1 Clinical Immunology and Allergy Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden; 2 Department of Biomedical Sciences and Veterinary Public Health, Swedish University of Agricultural Sciences, Uppsala, Sweden; and 3 Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia

Fc{epsilon}RI-activation–induced survival of mast cells is dependent on the expression and function of the prosurvival protein A1. The expression of A1 in lymphocytes and monocytes has previously been described to be transcriptionally regulated by NF-{kappa}B. Here we demonstrate that the expression of A1 in mast cells is not dependent on NF-{kappa}B but that NFAT plays a crucial role. Fc{epsilon}RI-induced A1 expression was not affected in mast cells overexpressing an I{kappa}B-{alpha} super-repressor or cells lacking NF-{kappa}B subunits RelA, c-Rel, or c-Rel plus NF-{kappa}B1 p50. In contrast, inhibition of calcineurin and NFAT by cyclosporin A abrogated the expression of A1 in mast cells on Fc{epsilon}RI-activation but had no effect on lipopolysaccharide-induced expression of A1 in J774A.1 monocytic cells. Cyclosporin A also inhibited luciferase expression in an A1 promoter reporter assay. A putative NFAT binding site in the A1 promoter showed inducible protein binding after Fc{epsilon}RI crosslinking or treatment with ionomycin as detected in a band shift assay or chromatin immunoprecipitation. The binding protein was identified as NFAT1. Finally, mast cells expressing constitutively active NFAT1 exhibit increased expression of A1 after Fc{epsilon}RI-stimulation. These results indicate that, in Fc{epsilon}RI stimulated mast cells, A1 is transcriptionally regulated by NFAT1 but not by NF-{kappa}B.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
Sponsor: Genentech BioOncology and and Biogen Idec
Blood Online is supported in part by
Genentech BioOncology and Biogen Idec
  Copyright © 2008 by American Society of Hematology         Online ISSN: 1528-0020